{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:50:39Z","timestamp":1740142239512,"version":"3.37.3"},"reference-count":22,"publisher":"Bentham Science Publishers Ltd.","issue":"41","funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ40838"],"award-info":[{"award-number":["2023JJ40838"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270752"],"award-info":[{"award-number":["82270752"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>Due to the confounding heterogeneity, the therapeutic strategy\nfor proliferative glomerulonephritis with monoclonal IgG deposits (PGNMID) remains\nto be defined.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Case Representation:<\/jats:title>\n<jats:p>We report a 38-year-old man with recurrent swelling of the eyelids\nand lower limbs, undergoing rituximab combined with steroid and tacrolimus treatment,\nwho achieved an improved renal outcome. Underlying solid malignant tumours\nwere excluded from the diagnosis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Discussion:<\/jats:title>\n<jats:p>We treated patients with rituximab along with steroids and tacrolimus. Improvements\nin proteinuria and renal function were observed. We also reviewed the current\nliterature to assess the efficacy of rituximab in the treatment of PGNMID.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>However, a larger pool of patients and a longer follow-up period are required\nto establish the role of rituximab and steroids in the treatment of PGNMID.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0109298673272183240108093135","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T08:13:51Z","timestamp":1708589631000},"page":"6902-6908","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rituximab Combined with Steroid and Tacrolimus Treats Proliferative Glomerulonephritis with Monoclonal IgG Deposits: A Case Report and Review of the Literature"],"prefix":"10.2174","volume":"31","author":[{"given":"Di","family":"Liu","sequence":"first","affiliation":[{"name":"Hunan Key Laboratory of Kidney Disease and Blood Purification, Department of Nephrology, The Second\nXiangya Hospital of Central South University, No. 139 Renmin Middle Rd, Changsha, 410011, Hunan,\nChina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Xia","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of Kidney Disease and Blood Purification, Department of Nephrology, The Second\nXiangya Hospital of Central South University, No. 139 Renmin Middle Rd, Changsha, 410011, Hunan,\nChina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Wang","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of Kidney Disease and Blood Purification, Department of Nephrology, The Second\nXiangya Hospital of Central South University, No. 139 Renmin Middle Rd, Changsha, 410011, Hunan,\nChina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejing","family":"Zhu","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of Kidney Disease and Blood Purification, Department of Nephrology, The Second\nXiangya Hospital of Central South University, No. 139 Renmin Middle Rd, Changsha, 410011, Hunan,\nChina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guochun","family":"Chen","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of Kidney Disease and Blood Purification, Department of Nephrology, The Second\nXiangya Hospital of Central South University, No. 139 Renmin Middle Rd, Changsha, 410011, Hunan,\nChina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of Kidney Disease and Blood Purification, Department of Nephrology, The Second\nXiangya Hospital of Central South University, No. 139 Renmin Middle Rd, Changsha, 410011, Hunan,\nChina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1523-1755.2004.00365.x","volume":"65","author":"Nasr S.H.","year":"2004","unstructured":"Nasr S.H.; Markowitz G.S.; Stokes M.B.; Seshan S.V.; Valderrama E.; Appel G.B.; Aucouturier P.; D\u2019Agati V.D.; Proliferative glomerulonephritis with monoclonal IgG deposits: A distinct entity mimicking immune-complex glomerulonephritis. Kidney Int  2004,65(1),85-96","journal-title":"Kidney Int"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1681\/ASN.2009010110","volume":"20","author":"Nasr S.H.","year":"2009","unstructured":"Nasr S.H.; Satoskar A.; Markowitz G.S.; Valeri A.M.; Appel G.B.; Stokes M.B.; Nadasdy T.; D\u2019Agati V.D.; Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol  2009,20(9),2055-2064","journal-title":"J Am Soc Nephrol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.4103\/0971-4065.151354","volume":"25","author":"Nada R.","year":"2015","unstructured":"Nada R.; Gowda K.K.; Ramachandran R.; Joshi K.; Tewari R.; Kohli H.S.; Jha V.; Gupta K.L.; Proliferative glomerulonephritis with monoclonal immunoglobulin deposition disease: The utility of routine staining with immunoglobulin light chains. Indian J Nephrol  2015,25(6),344-348","journal-title":"Indian J Nephrol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/ndt\/gfz176","volume":"36","author":"Bridoux F.","year":"2021","unstructured":"Bridoux F.; Javaugue V.; Nasr S.H.; Leung N.; Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: A nephrologist perspective. Nephrol Dial Transplant  2021,36(2),208-215","journal-title":"Nephrol Dial Transplant"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/j.ekir.2021.04.026","volume":"6","author":"Aucouturier P.","year":"2021","unstructured":"Aucouturier P.; D\u2019Agati V.D.; Ronco P.; A fresh perspective on monoclonal gammopathies of renal significance. Kidney Int Rep  2021,6(8),2059-2065","journal-title":"Kidney Int Rep"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1093\/ndt\/gfr251","volume":"26","author":"Barbour S.J.","year":"2011","unstructured":"Barbour S.J.; Beaulieu M.C.; Zalunardo N.Y.; Magil A.B.; Proliferative glomerulonephritis with monoclonal IgG deposits secondary to chronic lymphocytic leukemia. Report of two cases. Nephrol Dial Transplant  2011,26(8),2712-2714","journal-title":"Nephrol Dial Transplant"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2215\/CJN.05750710","volume":"6","author":"Nasr S.H.","year":"2011","unstructured":"Nasr S.H.; Sethi S.; Cornell L.D.; Fidler M.E.; Boelkins M.; Fervenza F.C.; Cosio F.G.; D\u2019Agati V.D.; Proliferative glomerulonephritis with monoclonal IgG deposits recurs in the allograft. Clin J Am Soc Nephrol  2011,6(1),122-132","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/nep.12773","volume":"21","author":"Tsuji T","year":"2016","unstructured":"Tsuji T; Miura M; Yanai M; De novo proliferative glomerulonephritis with monoclonal IgG deposits of the IgG1kappa subtype in a kidney allograft. Nephrology  2016,21(S1),44-47","journal-title":"Nephrology"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/ckj\/sfx001","volume":"10","author":"Merhi B.","year":"2017","unstructured":"Merhi B.; Patel N.; Bayliss G.; Henriksen K.J.; Gohh R.; Proliferative glomerulonephritis with monoclonal IgG deposits in two kidney allografts successfully treated with rituximab. Clin Kidney J  2017,10(3),405-410","journal-title":"Clin Kidney J"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000488641","volume":"8","author":"Torrealba J.","year":"2018","unstructured":"Torrealba J.; Gattineni J.; Hendricks A.R.; Proliferative glomerulonephritis with monoclonal immunoglobulin G lambda deposits: Report of the first pediatric case. Case Rep Nephrol Dial  2018,8(1),70-75","journal-title":"Case Rep Nephrol Dial"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s00467-018-3949-8","volume":"33","author":"Xing G.","year":"2018","unstructured":"Xing G.; Gillespie R.; Bedri B.; Quan A.; Zhang P.; Zhou X.J.; Proliferative glomerulonephritis with monoclonal IgG deposits in children and young adults. Pediatr Nephrol  2018,33(9),1531-1538","journal-title":"Pediatr Nephrol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"e225205","DOI":"10.1136\/bcr-2018-225205","volume":"11","author":"Maan D.","year":"2018","unstructured":"Maan D.; Clark B.; Bunker M.; Arora S.; Successful management of proliferative glomerulonephritis with monoclonal immune deposits with combined immunosuppressive therapy. BMJ Case Rep  2018,11(1),e225205","journal-title":"BMJ Case Rep"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12882-018-0969-3","volume":"19","author":"Wen J.","year":"2018","unstructured":"Wen J.; Wang W.; Xu F.; Chen J.; Zhang M.; Cheng D.; Ni X.; Li X.; Liu Z.; Clinicopathological analysis of proliferative glomerulonephritis with monoclonal IgG deposits in 5 renal allografts. BMC Nephrol  2018,19(1),173","journal-title":"BMC Nephrol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.kint.2018.02.020","volume":"94","author":"Gumber R.","year":"2018","unstructured":"Gumber R.; Cohen J.B.; Palmer M.B.; Kobrin S.M.; Vogl D.T.; Wasserstein A.G.; Nasta S.D.; Bleicher M.B.; Bloom R.D.; Dember L.; Cohen A.; Weiss B.M.; Hogan J.J.; A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits. Kidney Int  2018,94(1),199-205","journal-title":"Kidney Int"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/nep.12775","volume":"21","author":"Sawada A","year":"2016","unstructured":"Sawada A; Kawanishi K; Horita S; Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft. Nephrology  2016,21(S1),48-52","journal-title":"Nephrology"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1097\/TP.0000000000002577","volume":"103","author":"Buxeda A.","year":"2019","unstructured":"Buxeda A.; Said S.M.; Nasr S.H.; Leung N.; El Ters M.; Cosio F.G.; Recurrent proliferative glomerulonephritis with monoclonal immunoglobulin deposits in kidney allografts treated with anti-CD20 antibodies. Transplantation  2019,103(7),1477-1485","journal-title":"Transplantation"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","year":"2021","unstructured":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group 2021,100(4S),S1-S276","journal-title":"Kidney Int"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41598-021-03691-0","volume":"12","author":"Li Y.","year":"2022","unstructured":"Li Y.; Fu R.; Gao J.; Wang L.; Duan Z.; Tian L.; Ge H.; Ma X.; Zhang Y.; Li K.; Xu P.; Tian X.; Chen Z.; Effect of pulsed intravenous methylprednisolone with alternative low-dose prednisone on high-risk IgA nephropathy: A 18-month prospective clinical trial. Sci Rep  2022,12(1),255","journal-title":"Sci Rep"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.clinthera.2021.03.009","volume":"43","author":"Zhao J.","year":"2021","unstructured":"Zhao J.; Ma F.; Bai M.; Sun S.; Low-dose corticosteroid combined with mycophenolate mofetil for IgA Nephropathy with stage 3 or 4 CKD: A retrospective cohort study. Clin Ther  2021,43(5),859-870","journal-title":"Clin Ther"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1177\/1470320314568520","volume":"16","author":"Shengyou Y.","year":"2015","unstructured":"Shengyou Y.; Li Y.; Zhihong H.; Yuanyuan M.; Influence of tacrolimus on podocyte injury inducted by angiotensin II. J Renin Angiotensin Aldosterone Syst  2015,16(2),260-266","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"9810","DOI":"10.1111\/jcmm.15562","volume":"24","author":"Zhang S.","year":"2020","unstructured":"Zhang S.; Wang H.; Liu Y.; Yang W.; Liu J.; Han Y.; Liu Y.; Liu F.; Sun L.; Xiao L.; Tacrolimus ameliorates tubulointerstitial inflammation in diabetic nephropathy via inhibiting the NFATc1\/TRPC6 pathway. J Cell Mol Med  2020,24(17),9810-9824","journal-title":"J Cell Mol Med"},{"key":"ref=22","first-page":"8832114","author":"Ma R","year":"2021","unstructured":"Ma R; Wang Y; Xu Y.; Tacrolimus protects podocytes from apoptosis via downregulation of TRPC6 in diabetic nephropathy. J Diabetes Res  2021,8832114","journal-title":"J Diabetes Res"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673272183240108093135","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/227162\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673272183240108093135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T10:10:16Z","timestamp":1732183816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/227162\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":22,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673272183240108093135","relation":{},"ISSN":["0929-8673"],"issn-type":[{"type":"print","value":"0929-8673"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-08-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}